Australia markets closed

Hansoh Pharmaceutical Group Company Limited (3692.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
18.240+0.060 (+0.33%)
At close: 04:08PM HKT
Full screen
Previous close18.180
Open18.200
Bid18.220 x N/A
Ask18.240 x N/A
Day's range17.980 - 18.500
52-week range9.410 - 18.500
Volume3,364,767
Avg. volume5,632,844
Market cap108.165B
Beta (5Y monthly)0.56
PE ratio (TTM)32.57
EPS (TTM)0.560
Earnings date26 Mar 2024
Forward dividend & yield0.21 (1.17%)
Ex-dividend date19 June 2024
1y target est18.67
  • GlobeNewswire

    SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China

    JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.